Abstract:Abstract Background The positive transcription elongation factor b (P-TEFb) kinase activity is involved in the process of transcription. Cyclin-dependent kinase 9 (CDK9), a core component of P-TEFb, regulates the process of transcription elongation, which is associated with differentiation and apoptosis in many cancer types. Wogonin, a natural CDK9 inhibitor isolated from Scutellaria baicalensis. This study aimed to investigate the involved molecular mechanisms of wogonin on anti- chronic myeloid leukemia (CML) cells. Materials and methods mRNA and protein levels were analysed by RT-qPCR and western blot. Flow cytometry was used to assess cell differentiation and apoptosis. Cell transfection, immunofluorescence analysis and co-immunoprecipitation (co-IP) assays were applied to address the potential regulatory mechanism of wogonin. KU-812 cells xenograft NOD/SCID mice model was used to assess and verify the mechanism in vivo. Results We reported that the anti-CML effects in K562, KU-812 and primary CML cells induced by wogonin were regulated by P-TEFb complex. We also confirmed the relationship between CDK9 and erythroid differentiation via knockdown the expression of CDK9. For further study the mechanism of erythroid differentiation induced by wogonin, co-IP experiments were used to demonstrate that wogonin increased the binding between GATA-1 and FOG-1 but decreased the binding between GATA-1 and RUNX1, which were depended on P-TEFb. Also, wogonin induced apoptosis and decreased the mRNA and protein levels of MCL-1 in KU-812 cells, which is the downstream of P-TEFb. In vivo studies showed wogonin had good anti-tumor effects in KU-812 xenografts NOD/ SCID mice model and decreased the proportion of human CD45 + cells in spleens of mice. We also verified that wogonin exhibited anti-CML effects through modulating P-TEFb activity in vivo. Conclusions Our study indicated a special mechanism involving the regulation of P-TEFb kinase activity in CML cells, providing evidences for further application of wogonin in CML clinical treatment.

Wogonoside induces growth inhibition and cell cycle arrest via promoting the expression and binding activity of GATA-1 in chronic myelogenous leukemia cells

Wogonoside Induces Cell Cycle Arrest And Differentiation By Affecting Expression And Subcellular Localization Of Plscr1 In Aml Cells

Wogonoside Exerts Anti-Leukemia of AML Cells Via Restricting Phospholipid Scramblase 1 Gene Expression and Promoting Its Translocation into Nuclear

Wogonoside Impedes the Progression of Acute Myeloid Leukemia Through Inhibiting Bone Marrow Angiogenesis.

Wogonoside Exerts Growth-Suppressive Effects Against T Acute Lymphoblastic Leukemia Through the STAT3 Pathway

Wogonin reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12-CXCR4/7 axis in bone marrow microenvironment

Wogonin induces G<sub>1</sub> phase arrest through inhibiting Cdk4 and cyclin D1 concomitant with an elevation in p21<sup>Cip1</sup> in human cervical carcinoma HeLa cells

Wogonin Reverses Multi-Drug Resistance of Human Myelogenous Leukemia K562/A02 Cells Via Downregulation of MRP1 Expression by Inhibiting Nrf2/ARE Signaling Pathway.

Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia

Wogonoside Induces Apoptosis in Bel-7402, a Hepatocellular Carcinoma Cell Line, by Regulating Bax/Bcl-2.

Wogonin Induces the Granulocytic Differentiation of Human NB4 Promyelocytic Leukemia Cells and Up‐regulates Phospholipid Scramblase 1 Gene Expression

Wogonin, a Natural and Biologically-active Flavonoid, Influences a Murine WEHI-3 Leukemia Model in Vivo Through Enhancing Populations of T- and B-Cells

Wogonin Induced Differentiation and G1 Phase Arrest of Human U-937 Leukemia Cells Via PKCdelta Phosphorylation.

Deglycosylation of Wogonoside Enhances Its Anticancer Potential.

PLSCR1/IP3R1/Ca2+ Axis Contributes to Differentiation of Primary AML Cells Induced by Wogonoside.

Wogonoside induces autophagy-related apoptosis in human glioblastoma cells

Effect of Magnetic Nanoparticles on Apoptosis and Cell Cycle Induced by Wogonin in Raji Cells

Wogonoside induces autophagy in MDA-MB-231 cells by regulating MAPK-mTOR pathway

On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation

Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis.

Wogonin Inhibits WEHI‐3 Leukemia Cells in Blab/C Mice in Vivo